Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Water Soluble Silicon ...
Routine Notice Added Final

USPTO Patent Granted for Water Soluble Silicon Dioxide Formulation

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent for a water-soluble silicon dioxide formulation developed by Christina Rahm Cook. The formulation is designed for use in pharmaceuticals and nutraceuticals, aiming to provide intracellular detoxification and replenishment for living organisms.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582671B1 for a water-soluble electrolyzed silicon dioxide formulation and its method of manufacture. The patent, filed on September 26, 2023, by inventor Christina Rahm Cook, describes a formulation combining bio-available silicon dioxide fragments with vitamins, amino acids, nutrients, and minerals. The stated purpose is to facilitate intracellular detoxification, replenishment, and growth stimulation in living organisms, potentially improving the aging process. The formulation can be complexed with a metal ion and is available in various forms, including liquid capsules, slurry, gels, or syrups.

This patent grant represents a new intellectual property for a specific pharmaceutical and nutraceutical formulation. While patents do not impose direct regulatory obligations on other entities, they protect the inventor's rights and may influence market entry and product development strategies for competitors in the pharmaceutical and nutraceutical sectors. Companies developing similar formulations should be aware of this granted patent to avoid infringement. No compliance actions are immediately required for entities not involved with this specific patented technology.

Source document (simplified)

← USPTO Patent Grants

Water soluble electrolyzed silicon dioxide formulation and method of manufacture

Grant US12582671B1 Kind: B1 Mar 24, 2026

Inventors

Christina Rahm Cook

Abstract

The present invention relates generally to water soluble formulations for materials such as pharmaceuticals and nutraceuticals. The present invention includes a method and a formulation of bio-available silicon dioxide fragments combined with vitamins, amino acids, nutrient compounds, and minerals that can be utilized to detoxify, replenish and stimulate growth in living organisms providing benefits such as but not limited to improvements in the aging process. The formulation of the present invention is a water-soluble electrolyzed silicon dioxide formulation operable to provide intracellular detoxification wherein the composition of the present invention can further include minerals or vitamins. The water soluble electrolyzed silicon dioxide formulation of the present invention is operable to provide intracellular detoxification wherein the water-soluble hydrolyzed silicon dioxide fragments can be complexed with a metal ion. The formulation is provided in liquid capsules, slurry form, gels or syrups.

CPC Classifications

A61K 33/00 A61K 31/355 A61K 31/375 A61K 31/593 A61K 33/04 A61K 33/26 A61K 33/30 C01B 33/18

Filing Date

2023-09-26

Application No.

18372897

Claims

8

View original document →

Named provisions

Abstract Claims

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582671B1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Formulation Nutraceutical Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Nutraceuticals Medical Innovations

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.